首页> 外文OA文献 >A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

【2h】

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

机译：每周低剂量他莫昔芬与雷洛昔芬对安慰剂治疗女性绝经前妇女雌激素受体阳性乳腺癌的随机II期临床前试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Davide Serrano; Matteo Lazzeroni; Sara Gandini; Debora Macis; Harriet Johansson; Jennifer Gjerde; Ernst Lien; Irene Feroce; Giancarlo Pruneri; Maria Teresa Sandri; Fabio Bassi; Fabricio Brenelli; Alberto Luini; Massimiliano Cazzaniga; Clara Varricchio; Aliana Guerrieri-Gonzaga; Andrea DeCensi; Bernardo Bonanni;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer [J] . Davide Serrano, Matteo Lazzeroni, Sara Gandini, Breast Cancer Research . 2013,第3期

机译：每周低剂量他莫昔芬与雷洛昔芬与安慰剂联合治疗绝经前女性雌激素受体阳性乳腺癌的II期随机临床试验
2. Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study) [J] . Kim Ji-Yeon, Im Seock-Ah, Jung Kyung Hae, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：Fulvestrant Plus Goserelin与Anstrozole Plus Goserelin与戈萨雷啉单独用于激素受体阳性，Her2阴性Tamoxifen-Prementeated患有复发性或转移性乳腺癌的预处理女性（KCSG BR10-04）：多期，开放标签，三臂，随机阶段 II试验（旗帜研究）
3. Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor-Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group [J] . Tevaarwerk Amye J., Wang Molin, Zhao Fengmin, Journal of Clinical Oncology . 2014,第35期

机译：三苯氧胺与三苯氧胺加卵巢功能抑制在结节阴性，激素受体阳性乳腺癌的绝经前妇女中的三阶段比较（E-3193，INT-0142）：东方合作肿瘤小组的一项试验
4. Molecular Biology of the Estrogen Receptor Aids in the Understanding of Tamoxifen Resistance and Breast Cancer Prevention with Raloxifene* [C] . International Conference on "Adjuvant Therapy of Primary Breast Cancer" . 1998

机译：雌激素受体的分子生物学艾滋病了解罗洛昔芬的制革氧抗性和乳腺癌预防
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer [O] . Davide Serrano, Matteo Lazzeroni, Sara Gandini, 2013

机译：每周低剂量他莫昔芬与雷洛昔芬对安慰剂治疗女性绝经前妇女雌激素受体阳性乳腺癌的随机II期临床前试验
7. A randomized phase II pre-surgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor positive breast cancer [O] . Serrano, Davide, Lazzeroni, Matteo, Gandini, Sara, 2013

机译：一项关于雌激素受体阳性乳腺癌的绝经前妇女每周低剂量他莫昔芬与雷洛昔芬与安慰剂相比的随机II期手术前试验

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅